Telepatia

If you require independently verifiable enterprise security certifications

• If procurement requires SOC 2 Type II or ISO 27001 certificates as a firm prerequisite, the vendor’s public materials did not provide these attestations in the sources reviewed.

If you require abundant third-party user reviews before buying

• The vendor has limited visibility on major review platforms based on the sources retrieved; buyers who rely heavily on third-party review signals may prefer vendors with more publicly available references.

If you operate in a deeply Epic-standardized environment (particularly outside Latin America)

• Competitors that emphasize Epic alignment may have distribution or integration advantages in Epic-dominant settings.

If your organization cannot implement clinical governance for AI decision support

• The vendor’s CDSS offering requires local governance and oversight; organizations that cannot or will not implement such governance should be cautious.

If you need transparent, published enterprise pricing

• The vendor does not publish clear enterprise pricing tiers in the sources reviewed; procurement teams that require upfront line-item pricing may prefer vendors with published tiers or more consistent third-party pricing disclosure.

Public information gaps (material for procurement)

• Formal security certifications (e.g., SOC 2 Type II, ISO 27001) are not publicly documented in the sources reviewed
• No public subprocessors list was found in the materials reviewed
• No public enterprise pricing details were found for institutional deployments
• Portions of the vendor security page appear incomplete or to contain placeholder text, which can raise questions during vendor due diligence

Roadmap / not yet available

• The vendor lists an "AI Nurse" capability as a planned feature for WhatsApp-based workflows; its availability and capabilities remain to be demonstrated.

Scale limitations

• The vendor does not publicly document load/performance characteristics, uptime history, or formal support SLA commitments in the materials reviewed; buyers should request these items for enterprise evaluation.

CDSS governance limitations

• Vendor legal language emphasizes that clinical responsibility remains with licensed clinicians; this is standard but highlights the need for local governance and monitoring of CDSS outputs.

Vendor-emphasized features and positioning (based on available evidence)

• Regional focus: the vendor emphasizes Latin America localization and multilingual support (Portuguese/Spanish) and references local data protection frameworks.
• Integrated suite approach: the vendor presents a combined offering that includes scribing, CDSS, integrations, and BI reporting within one product family.
• Jurisdictional legal documentation: the vendor publishes Terms and Privacy documents for multiple jurisdictions (Brazil and Colombia), which provides some baseline transparency for buyers.

Where competitors have advantages

• Some competitors have more visible enterprise adoption narratives, documented EHR partnerships, and more extensive third-party evaluation footprints.

• An implementation report describing deployments of Telepatia AI Scribe and Telepatia CDSS in primary care settings in Colombia and Brazil.

• The report provides more operational detail than vendor marketing and may be useful for evaluating implementation considerations.

• The document is a preprint and not a final peer-reviewed publication. Reviewers should look for details such as error types and correction workflows, how CDSS recommendations are sourced and version-controlled, safety monitoring and incident reporting, and clinician satisfaction over longer follow-up periods.

Company sizes

• Institutional
  • Multi-clinic groups, hospitals, and payers/insurers seeking protocol adherence analytics and operational BI.
  • Likely best fit where an internal IT team can support integration and governance.
• Individual clinicians
  • Independent physicians who may adopt a free or low-cost scribe solution where local EHR complexity is moderate and workflows are repeatable.

Industries and verticals

• Provider organizations across Latin America
• Health insurers/operadoras focused on protocol adherence and claims cost management
• Primary care settings (consistent with the implementation report context)

Roles and personas

• Decision makers: CMIOs/clinical directors, COOs/CIOs/CTOs for integration and data governance, and executive leadership at provider networks
• End users: Physicians in high-volume outpatient settings and clinical leadership responsible for protocols and quality

Pain points and challenges the product addresses

• Documentation burden and clinician burnout
• Variability in care and protocol non-adherence
• Fragmented health IT ecosystems requiring integrations
• Limited operational visibility into clinical KPIs

Qualification criteria (what makes a GOOD fit)

• Multilingual care settings (Spanish/Portuguese)
• Commitment to standardized protocols and measurement
• Willingness to implement governance for AI decision support
• Need for integration across multiple health systems rather than a single, standardized U.S. EHR environment

Deal disqualifiers (what makes a POOR fit)

• Organizations that require publicly verifiable SOC 2 Type II or ISO 27001 attestations as a hard procurement gate (these were not publicly documented in the sources reviewed)
• Workflows or regulatory environments that prohibit ambient audio capture or make it operationally infeasible due to consent requirements
• Teams that require extensive third-party review coverage and long public track records before adopting safety-adjacent AI tools

Real customer examples

• The vendor site lists clinician names and quotations in marketing materials but does not provide a clear public list of institutional customers in the materials reviewed.

• AI Scribe ("IA Redatora"): listens to clinician–patient conversations and generates structured clinical documentation in real time.
• AI Doctor / Clinical Copilot ("IA Conselheira"): provides guidance and evidence-based suggestions intended to align with institutional protocols.
• AI Integration ("IA Integradora"): integrates with electronic health records and other health systems to reduce manual data transfer.
• AI Business Intelligence: dashboards reporting on protocol adherence, clinical quality/performance, and operational KPIs.
• AI Nurse (listed as a planned feature): described for WhatsApp-based pre-charting and follow-ups.

• Vendor reports clinicians can save multiple hours per day per clinician.
• Vendor reports a noticeable increase in protocol adherence.
• Vendor reports integrations with many systems.
• Vendor reports high aggregate usage and a small client footprint, and states it has received multi-million dollar investment on its public materials.

• Physicians concerned with documentation time and administrative burden
• Clinical directors focused on documentation quality, protocol adherence, and variability reduction
• Executives seeking KPI visibility at scale